IL6R and Fabry disease: No difference was found in the levels of soluble IL-6R between FD patients with (n = 14) and those without (n = 6) therapy (29.5 ± 9.6 ng/mL vs. 30.0 ± 5.9 ng/mL, p < 0.0001).